{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T22:51:59Z","timestamp":1786747919298,"version":"build-2736575974"},"reference-count":42,"publisher":"Georg Thieme Verlag KG","issue":"08","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"crossref","award":["No. 813409"],"award-info":[{"award-number":["No. 813409"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>\n            Background\u2003Residual venous obstruction (RVO) is considered a risk factor of recurrence and possibly other clinical outcomes following deep vein thrombosis (DVT). Current guidelines do not support an RVO-tailored duration of anticoagulant therapy; contemporary data of such management strategies are scarce. We aimed to evaluate an RVO-based management strategy and to assess associations of RVO with recurrence, post-thrombotic syndrome (PTS), arterial events and cancer. To gain further insight, D-dimer levels were measured 1 month after stopping anticoagulant therapy.<\/jats:p><jats:p>\n            Methods\u2003Consecutive patients with symptomatic, proximal DVT were treated in a 2-year clinical care pathway (CCP) at Maastricht University Medical Center and were followed up to 5 years. RVO was assessed at the end of regular duration of anticoagulant therapy, which was extended once if RVO was detected. The study was approved by the medical ethics committee.<\/jats:p><jats:p>\n            Result\u2003From a total of 825 patients, 804 patients (97.5%) completed the CCP and 755 (93.9%) were available for extended follow-up. Most patients (76.5%) stopped anticoagulant therapy. Incidence rates of recurrence, PTS, arterial events, and cancer were 4.4, 11.9, 1.7, and 1.8 per 100 patient-years, respectively. RVO was independently associated with PTS (hazard ratio [HR]: 1.66 [1.19\u20132.32]) and arterial events (HR: 2.07 [1.18\u20133.65]), but not with recurrence or cancer. High D-dimer was associated with recurrence (HR: 3.51 [2.24\u20135.48]).<\/jats:p><jats:p>\n            Conclusion\u2003Our RVO-based management strategy might have attenuated the association of RVO with recurrence. In addition, RVO identified patients at increased risk of PTS and arterial events, which might be used to identify patients in need of alternative treatment strategies.<\/jats:p>","DOI":"10.1055\/a-2059-4737","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T23:48:55Z","timestamp":1679442535000},"page":"763-772","source":"Crossref","is-referenced-by-count":17,"title":["Residual Venous Obstruction as an Indicator of Clinical Outcomes following Deep Vein Thrombosis: A Management Study"],"prefix":"10.1055","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2880-6850","authenticated-orcid":false,"given":"Aaron F. J.","family":"Iding","sequence":"additional","affiliation":[{"name":"Thrombosis Expertise Center, Heart\u2009+\u2009Vascular Center, Maastricht University Medical Center, Maastricht, the Netherlands"},{"name":"Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram M. M.","family":"Kremers","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Pallares Robles","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands"},{"name":"Center of Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7796-4463","authenticated-orcid":false,"given":"Hugo","family":"ten Cate","sequence":"additional","affiliation":[{"name":"Thrombosis Expertise Center, Heart\u2009+\u2009Vascular Center, Maastricht University Medical Center, Maastricht, the Netherlands"},{"name":"Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands"},{"name":"Center of Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany"},{"name":"Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arina J.","family":"ten Cate-Hoek","sequence":"additional","affiliation":[{"name":"Thrombosis Expertise Center, Heart\u2009+\u2009Vascular Center, Maastricht University Medical Center, Maastricht, the Netherlands"},{"name":"Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"F Khan","year":"2021","journal-title":"Lancet"},{"issue":"09","key":"ref2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/CIRCULATIONAHA.117.031354","article-title":"Prognostic significance of nuisance bleeding in anticoagulated patients with atrial fibrillation","volume":"138","author":"E C O'Brien","year":"2018","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1477-7525-7-30","article-title":"Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q)","volume":"7","author":"M H Prins","year":"2009","journal-title":"Health Qual Life Outcomes"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.chest.2021.07.056","article-title":"Executive summary: Antithrombotic therapy for VTE disease: Second update of the CHEST guideline and expert panel report","volume":"160","author":"S M Stevens","year":"2021","journal-title":"Chest"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor's choice - European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis","volume":"61","author":"S K Kakkos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"19","key":"ref6","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"T L Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"m1565","DOI":"10.1136\/bmj.m1565","article-title":"Venous thromboembolism in adults: summary of updated NICE guidance on diagnosis, management, and thrombophilia testing","volume":"369","author":"T McCormack","year":"2020","journal-title":"BMJ"},{"issue":"07","key":"ref8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1182\/bloodadvances.2018017160","article-title":"Risk of recurrent venous thromboembolism according to baseline risk factor profiles","volume":"2","author":"M H Prins","year":"2018","journal-title":"Blood Adv"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.thromres.2015.02.001","article-title":"Duration of anticoagulation after venous thromboembolism in real world clinical practice","volume":"135","author":"W Ageno","year":"2015","journal-title":"Thromb Res"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.3324\/haematol.2018.209924","article-title":"Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study","volume":"104","author":"V T Cate","year":"2019","journal-title":"Haematologica"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11739-021-02765-1","article-title":"Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries-the prospective, international, observational WHITE study","volume":"17","author":"G Palareti","year":"2022","journal-title":"Intern Emerg Med"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1538-7836.2011.04254.x","article-title":"Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis","volume":"9","author":"M Carrier","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2141.2011.08578.x","article-title":"Residual venous thrombosis as predictive factor for recurrent venous thromboembolism in patients with proximal deep vein thrombosis: a systematic review","volume":"153","author":"M Tan","year":"2011","journal-title":"Br J Haematol"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.blre.2015.09.002","article-title":"The post thrombotic syndrome: Ignore it and it will come back to bite you","volume":"30","author":"A J ten Cate-Hoek","year":"2016","journal-title":"Blood Rev"},{"issue":"09","key":"ref15","first-page":"CD004174","article-title":"Compression therapy for prevention of post-thrombotic syndrome","volume":"9","author":"D Appelen","year":"2017","journal-title":"Cochrane Database Syst Rev Wiley"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1538-7836.2010.03777.x","article-title":"Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis","volume":"8","author":"C Becattini","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7326\/0003-4819-149-5-200809020-00007","article-title":"Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?","volume":"149","author":"M Carrier","year":"2008","journal-title":"Ann Intern Med"},{"issue":"08","key":"ref18","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1055\/s-0038-1666859","article-title":"Predicting post-thrombotic syndrome with ultrasonographic follow-up after deep vein thrombosis: a systematic review and meta-analysis","volume":"118","author":"C EA Dronkers","year":"2018","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0035-1544161","article-title":"The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation","volume":"41","author":"P Prandoni","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3324\/haematol.2021.279680","article-title":"Elastic compression stockings for prevention of the post-thrombotic syndrome in patients with and without residual vein thrombosis and\/or popliteal valve reflux","volume":"107","author":"P Prandoni","year":"2022","journal-title":"Haematologica"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-137-12-200212170-00008","article-title":"Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism","volume":"137","author":"P Prandoni","year":"2002","journal-title":"Ann Intern Med"},{"issue":"05","key":"ref22","first-page":"515","article-title":"Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis","volume":"87","author":"F Piovella","year":"2002","journal-title":"Haematologica"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/rth2.12079","article-title":"Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction","volume":"2","author":"M Nagler","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1160\/TH13-04-0336","article-title":"Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis","volume":"111","author":"M P Donadini","year":"2014","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref25","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/j.1538-7836.2012.04827.x","article-title":"Interobserver reliability of compression ultrasound for residual thrombosis after first unprovoked deep vein thrombosis","volume":"10","author":"M Tan","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1538-7836.2010.04137.x","article-title":"High percentage of non-diagnostic compression ultrasonography results and the diagnosis of ipsilateral recurrent proximal deep vein thrombosis: a rebuttal","volume":"9","author":"S Hassen","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1182\/blood-2014-01-548065","article-title":"D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study","volume":"124","author":"G Palareti","year":"2014","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.thromres.2017.04.002","article-title":"Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis","volume":"154","author":"P Prandoni","year":"2017","journal-title":"Thromb Res"},{"issue":"03","key":"ref30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2008-01-131656","article-title":"Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study","volume":"112","author":"S Siragusa","year":"2008","journal-title":"Blood"},{"issue":"09","key":"ref31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-150-9-200905050-00003","article-title":"Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial","volume":"150","author":"P Prandoni","year":"2009","journal-title":"Ann Intern Med"},{"issue":"02","key":"ref32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1067\/mva.2002.121066","article-title":"Coagulation, fibrinolysis, and recanalization after acute deep venous thrombosis","volume":"35","author":"M H Meissner","year":"2002","journal-title":"J Vasc Surg"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3389\/fimmu.2019.01348","article-title":"Fibrinolysis and inflammation in venous thrombus resolution","volume":"10","author":"S Mukhopadhyay","year":"2019","journal-title":"Front Immunol"},{"issue":"08","key":"ref34","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1538-7836.2012.04798.x","article-title":"Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome","volume":"10","author":"A C Bouman","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11739-019-02238-6","article-title":"Is there a link between venous and arterial thrombosis? A reappraisal","volume":"15","author":"P Prandoni","year":"2020","journal-title":"Intern Emerg Med"},{"issue":"12","key":"ref36","first-page":"CD011088","article-title":"Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism","volume":"12","author":"L Robertson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"05","key":"ref37","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.chest.2022.05.038","article-title":"Anticoagulation for VTE: Impact on the risk of major adverse cardiovascular events","volume":"162","author":"S R Noumegni","year":"2022","journal-title":"Chest"},{"issue":"05","key":"ref38","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.chest.2022.08.2201","article-title":"Time to use direct oral anticoagulants to prevent recurrences and major acute cardiovascular events after VTE?","volume":"162","author":"C Becattini","year":"2022","journal-title":"Chest"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3390\/ijms21062080","article-title":"Resolution of deep venous thrombosis: Proposed immune paradigms","volume":"21","author":"J M Nicklas","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bjh.16275","article-title":"A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study)","volume":"188","author":"C Bradbury","year":"2020","journal-title":"Br J Haematol"},{"issue":"04","key":"ref41","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1538-7836.2006.01795.x","article-title":"Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months","volume":"4","author":"S Schulman","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jvsv.2013.07.001","article-title":"Biomarkers for post-thrombotic syndrome","volume":"2","author":"A C Bouman","year":"2014","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.thromres.2017.06.036","article-title":"An association between residual vein thrombosis and subclinical atherosclerosis: cross-sectional study","volume":"157","author":"P Prandoni","year":"2017","journal-title":"Thromb Res"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2059-4737.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T23:05:48Z","timestamp":1690326348000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2059-4737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":42,"journal-issue":{"issue":"08","published-online":{"date-parts":[[2023,7,24]]},"published-print":{"date-parts":[[2023,8]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2059-4737","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,21]]},"published":{"date-parts":[[2023,3,21]]}}}